Google DeepMind, Isomorphic Labs detail AI bioresilience strategy

Google DeepMind and Isomorphic Labs published a joint approach describing how they assess and mitigate biosecurity risks tied to their AI models, particularly around biological design capabilities.

Why it matters: As AI models get better at protein and molecule design, frontier labs face pressure to show credible dual-use biosecurity safeguards; this joins a short list of public lab policies (alongside OpenAI's internal red-teaming disclosures) addressing bio risk directly rather than leaving it implicit.